CHRNA3 genotype, nicotine dependence, lung function and disease in the general population Source: Eur Respir J 2012; 40: 1538-1544 Year: 2012
Lung cancer in patient with chronic obstructive pulmonary disease (comorbidity by smokers-a cumulative effect of exogenic and endogenic factors? Part II) Source: Annual Congress 2013 –COPD treatment Year: 2013
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history Source: Eur Respir J 2009; 33: 380-386 Year: 2009
Leptin receptor polymorphisms and lung function decline in COPD Source: Eur Respir J 2009; 34: 103-110 Year: 2009
?2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies Source: Eur Respir J 2012; 39: 558-566 Year: 2012
Polymorphic variants of genes ADRB2, NR3C1, MDR1 in patients with chronic obstructive pulmonary disease and obesity Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015
Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals Source: Eur Respir J 2011; 37: 791-799 Year: 2011
Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients Source: Eur Respir J 2008; 32: 372-378 Year: 2008
The impact of chronic obstructive pulmonary disease on survival of the patients with small-cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015
The positive effect of cilomilast on lung function in patients with chronic obstructive pulmonary disease (COPD) is independent of patient smoking status Source: Eur Respir J 2002; 20: Suppl. 38, 620s Year: 2002
Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007
Stratified medicine: drugs meet genetics Source: Eur Respir Rev 2013; 22: 53-57 Year: 2013
Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007
Is the COPD-index a significant prognostic factor of functional results of lobectomy in COPD patients? Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery Year: 2007
Expression of MIC-A in bronchial epithelium associates with cigarette smoking: a sign of induced autoimmune mechanisms? Source: Annual Congress 2005 - Lung structure: current concepts Year: 2005
Screening for α1-Pi deficiency in patients with lung diseases Source: Eur Respir J 2002; 20: 319-324 Year: 2002
Lobectomy at patients with lung cancer and a chronic obstructive pulmonary disease as analogue of lung volume reduction surgery in COPD patients: To do or not to do? Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013
The utility of HLA-DQB302 as a genetic marker to predict the effect of aspirin desensitization on lung function of patients with aspirin exacerbated respiratory disease Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015
The effect of smoking on lung function: a clinical study of adult-onset asthma Source: Eur Respir J 2016; 48: 1298-1306 Year: 2016
Determinants of success Source: Eur Respir J 2011; 38: 1215-1218 Year: 2011